{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for amphotericin root_notes_note in Note (approximate match)
Status:
Possibly Marketed Outside US
Source:
BLA125127
(2005)
Source URL:
First approved in 2005
Source:
BLA125127
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT00282295: Phase 4 Interventional Completed Acellular Pertussis
(2006)
Source URL:
First approved in 2005
Source:
BLA125089
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125020
(2003)
Source URL:
First approved in 2003
Source:
BLA125020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125020
(2003)
Source URL:
First approved in 2003
Source:
BLA125020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125020
(2003)
Source URL:
First approved in 2003
Source:
BLA125020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125034
(2003)
Source URL:
First approved in 2003
Source:
BLA125034
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M012
(2024)
Source URL:
First approved in 1999
Source:
ANDA209886
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02121145: Phase 4 Interventional Unknown status Healthy
(2013)
Source URL:
First approved in 1992
Source:
BLA103123
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA103914
(1980)
Source URL:
First approved in 1980
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2025)
Source URL:
First approved in 1956
Source:
ANDA091382
Source URL:
Class:
STRUCTURALLY DIVERSE